STEWARTVILLE, Minn., Jan. 18, 2011 /PRNewswire/ -- Rochester Medical Corporation (Nasdaq: ROCM) will announce quarterly results after financial markets close on Tuesday, January 25, 2011. The Company will then hold a quarterly conference call to discuss its earnings report. The Company also plans to discuss its agreement to acquire Laprolan B.V. as announced January 12, 2011. The call will begin at 3:30 p.m. central time (4:30 p.m. eastern time).
This call is being webcast by Thomson/CCBN and can be accessed at Rochester Medical’s website at www.rocm.com. To listen live to the conference call via telephone, call:
Domestic: | 888.679.8040 | |
International: | 617.213.4851 | |
Pass code: | 70488311 | |
Pre Registration:https://www.theconferencingservice.com/prereg/key.process?key=PGQ9HKPHX | ||
Replay will be available for seven days at www.rocm.com or via telephone at: | ||
Domestic: | 888-286-8010 | |
International: | 617-801-6888 | |
Pass code: | 98617625 | |
The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at www.fulldisclosure.com, Thomson/CCBN’s individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson’s password-protected event management site, StreetEvents (www.streetevents.com).
Rochester Medical Corporation develops, manufactures, and markets latex-free disposable medical catheters and devices for urological and continence care applications. The Company markets under its own Rochester Medical® brand and under existing private label arrangements.
For further information, please contact Anthony J. Conway, President and Chief Executive Officer or David A. Jonas, Chief Financial Officer of Rochester Medical Corporation at (507) 533-9600. More information about Rochester Medical is available on its website at http://www.rocm.com.
SOURCE Rochester Medical Corporation
